The DOI matches its Crossref record; 351 of the 357 references it cites were found in a registry or an index.
Androgen Receptor (AR) Coregulators: An Overview
Abstract
The biological action of androgens is mediated through the androgen receptor (AR). Androgen-bound AR functions as a transcription factor to regulate genes involved in an array of physiological processes, most notably male sexual differentiation and maturation, and the maintenance of spermatogenesis. The transcriptional activity of AR is affected by coregulators that influence a number of functional properties of AR, including ligand selectivity and DNA binding capacity. As the promoter of target genes, coregulators participate in DNA modification, either directly through modification of histones or indirectly by the recruitment of chromatin-modifying complexes, as well as functioning in the recruitment of the basal transcriptional machinery. Aberrant coregulator activity due to mutation or altered expression levels may be a contributing factor in the progression of diseases related to AR activity, such as prostate cancer. AR demonstrates distinct differences in its interaction with coregulators from other steroid receptors due to differences in the functional interaction between AR domains, possibly resulting in alterations in the dynamic interactions between coregulator complexes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgen receptors can be modulated by specific proteins called coregulators [70–72] or mediated via the activation of membrane-bound protein receptors to initiate intracellular signalling pathways [73], which can occur even in the presence of low levels of androgens [74].”
From Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus Statement (2021) · cites this paper as [70]
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M., & O’Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,887
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,759
Flagged first, then by citations
6 of the 357 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 943
Cheng, H., Snoek, R., Ghaidi, F., Cox, M., & Rennie, P. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0028 · Cited by 127
Role of the Steroid Receptor Coactivator SRC-3 in Cell Growth
Zhou, G., Hashimoto, Y., Kwak, I., Tsai, S. Y., & Tsai, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7742-7755.2003 · Cited by 128
19‐Nortestosterone influences neural stem cell proliferation and neurogenesis in the rat brain
Brännvall, K., Bogdanović, N., Korhonen, L., & Lindholm, D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03942.x · Cited by 127
Androgen Activation of the Sterol Regulatory Element-Binding Protein Pathway: Current Insights
Heemers, H. V., Verhoeven, G., & Swinnen, J. V. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0479 · Cited by 126
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
Burd, C. J., Petre, C. E., Morey, L. M., Wang, Y., Revelo, M. P., Haiman, C. A., Lu, S., Fenoglio‐Preiser, C. M., Li, J., Knudsen, E. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506281103 · Cited by 125
Snoek, R., Cheng, H., Margiotti, K., Wafa, L. A., Wong, C. A., Wong, E. C., Fazli, L., Nelson, C. C., Gleave, M. E., & Rennie, P. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1726 · Cited by 126
Differential Requirement of SWI/SNF for Androgen Receptor Activity
Marshall, T. W., Link, K. A., Petre, C. E., & Knudsen, K. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304582200 · Cited by 121
Blessing, A. M., Rajapakshe, K., Bollu, L. R., Shi, Y., White, M. A., Pham, A. H., Lin, C., Jonsson, P., Cortés, C. J., Cheung, E. C. W., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1268300 · Cited by 120
The role of the polyglutamine tract in androgen receptor
Palazzolo, I., Gliozzi, A., Rusmini, P., Sau, D., Crippa, V., Simonini, F., Onesto, E., Bolzoni, E., & Poletti, A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.016 · Cited by 123
Androgen receptor function is modulated by the tissue-specific AR45 variant
Ahrens‐Fath, I., Politz, O., Geserick, C., & Haendler, B. (2004) · FEBS Journal · doi:10.1111/j.1432-1033.2004.04395.x · Cited by 119
Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor
Dubbink, H. J., Hersmus, R., Verma, C. S., van der Korput, H. A. G. M., Berrevoets, C. A., van Tol, J., Ziel-van der Made, A. C. J., Brinkmann, A. O., Pike, A. C. W., & Trapman, J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0375 · Cited by 118
Signal transduction in prostate cancer progression
Gioeli, D. G. (2005) · Clinical Science · doi:10.1042/cs20040329 · Cited by 117
Dose-Dependent Effects of Androgens on Outcome after Focal Cerebral Ischemia in Adult Male Mice
Uchida, M., Palmateer, J., Herson, P. S., DeVries, A. C., Cheng, J., & Hurn, P. D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.60 · Cited by 118
Regulation of androgen receptor levels: Implications for prostate cancer progression and therapy
Burnstein, K. L. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20460 · Cited by 117
G Proteins in Cancer: The Prostate Cancer Paradigm
Daaka, Y. (2004) · Science s STKE · doi:10.1126/stke.2162004re2 · Cited by 117
Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments
Le, T. K., Duong, Q. H., Baylot, V., Fargette, C., Baboudjian, M., Colleaux, L., Taïeb, D., & Rocchi, P. (2023) · Cancers · doi:10.3390/cancers15205047 · Cited by 125
Androgen regulation of gene expression.
(2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07005-3 · Cited by 117
Analysis of Wnt Gene Expression in Prostate Cancer
Zhu, H., Mazor, M., Kawano, Y., Walker, M. M., Leung, H. Y., Armstrong, K., Waxman, J., & Kypta, R. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2704 · Cited by 115
Androgen receptor corepressors: An overview
Wang, L., Hsu, C., & Chang, C. (2004) · The Prostate · doi:10.1002/pros.20170 · Cited by 115
Self-citationCare of women with XY karyotype: a clinical practice guideline
Jørgensen, P. B., Kjartansdóttir, K. R., & Fedder, J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.087 · Cited by 114
Anti-androgenic mechanisms of Bisphenol A involve androgen receptor signaling pathway
Wang, H., Ding, Z., Shi, Q.-M., Ge, X., Wang, H.-X., Li, M.-X., Chen, G., Wang, Q., Ju, Q., Zhang, J., et al. (2017) · Toxicology · doi:10.1016/j.tox.2017.06.007 · Cited by 113
Negative Modulation of Androgen Receptor Transcriptional Activity by Daxx
Lin, D.-Y., Fang, H.-I., Ma, A., Huang, Y., Pu, Y., Jenster, G. W., Kung, H.-J., & Shih, H.-M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10529-10541.2004 · Cited by 111
Sone, K., Hinago, M., Itamoto, M., Katsu, Y., Watanabe, H., Urushitani, H., Tooi, O., Guillette, L. J., & Iguchi, T. (2005) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2005.03.007 · Cited by 110
Lange, C., Gioeli, D., Hammes, S., & Marker, P. C. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160319 · Cited by 122
Ianculescu, I., Wu, D., Siegmund, K. D., & Stallcup, M. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300194 · Cited by 107
Androgen Deprivation Increases p300 Expression in Prostate Cancer Cells
Heemers, H. V., Sebo, T. J., Debes, J. D., Regan, K. M., Raclaw, K. A., Murphy, L. M., Hobisch, A., Čulig, Z., & Tindall, D. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2836 · Cited by 111
Greco, E. A., Spera, G., & Aversa, A. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.049 · Cited by 106
Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer
Freeman, M. R., Cinar, B., & Lu, M. L. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.06.002 · Cited by 103
Chromatin remodeling by nuclear receptors
Hebbar, P. B., & Archer, T. (2003) · Chromosoma · doi:10.1007/s00412-003-0232-x · Cited by 106
Prostate cancer-associated lncRNAs
Mitobe, Y., Takayama, K., Horie‐Inoue, K., & Inoue, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.012 · Cited by 108
A Coregulatory Role for the TRAP-Mediator Complex in Androgen Receptor-mediated Gene Expression
Wang, Q., Sharma, D., Ren, Y., & Fondell, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206061200 · Cited by 104
Harada, N., Yasunaga, R., Higashimura, Y., Yamaji, R., Fujimoto, K., Moss, J., Inui, H., & Nakano, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610724200 · Cited by 105
Androgen Receptor Coregulators in Prostate Cancer
Rahman, M. M., Miyamoto, H., & Chang, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0746-3 · Cited by 103
Self-citationYuan, H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi021 · Cited by 102
Androgen receptor immunoreactivity in skeletal muscle: Enrichment at the neuromuscular junction
Monks, D. A., O’Bryant, E. L., & Jordan, C. L. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20088 · Cited by 102
Yoon, H.-G., & Wong, J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0324 · Cited by 120
Beneficial and Adverse Effects of Testosterone on the Cardiovascular System in Men
Ruige, J. B., Ouwens, D. M., & Kaufman, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1970 · Cited by 100
Molecular Genetic of Human Male Infertility: From Genes to New Therapeutic Perspectives
Vogt, P. H. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453261 · Cited by 100
Hu, Y., Yeh, S., Yeh, S.-D., Sampson, E. R., Huang, J., Li, P., Hsu, C.-L., Ting, H., Lin, H., Wang, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401781200 · Cited by 98
Self-citationThe polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons
Poletti, A. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.03.001 · Cited by 100
Dai, Y., Ngo, D., Forman, L. W., Qin, D. C., Jacob, J., & Faller, D. V. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0467 · Cited by 96
Gao, S., Liu, G., & Wang, Z. (2003) · The Prostate · doi:10.1002/pros.10375 · Cited by 96
Kikuchi, M., Okumura, F., Tsukiyama, T., Watanabe, M., Miyajima, N., Tanaka, J., Imamura, M., & Hatakeyama, S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.11.001 · Cited by 95
Villavicencio, A. N. P., Bacallao, K., Avellaira, C., Gabler, F., Fuentes, A., & Vega, M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.03.029 · Cited by 94
Meyer, R., Wolf, S. S., & Obendorf, M. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.006 · Cited by 93
Lai, K., Huang, C.-K., Chang, Y., Chung, C., Yamashita, S., Li, L., Lee, S. O., Yeh, S., & Chang, C. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.10.029 · Cited by 93
Self-citationChang, C., Yeh, S., Lee, S. O., & Chang, T. (2013) · Nuclear Receptor Signaling · doi:10.1621/nrs.11001 · Cited by 92
Self-citationKuwahara, S., Ikei, A., Taguchi, Y., Tabuchi, Y., Fujimoto, N., Obinata, M., Uesugi, S., & Kurihara, Y. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.051136 · Cited by 92
Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs
He, B., & Wilson, E. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2135-2150.2003 · Cited by 92
Li, J., Fu, J., Toumazou, C., Yoon, H., & Wong, J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0298 · Cited by 92
The Deubiquitinating Enzyme USP26 Is a Regulator of Androgen Receptor Signaling
Dirac, A. M. G., & Bernards, R. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0424 · Cited by 91
Hosohata, K., Li, P., Hosohata, Y., Qin, J., Roeder, R. G., & Wang, Z. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.7019-7029.2003 · Cited by 91
Molecular communication between androgen receptor and general transcription machinery
Lee, D. K., & Chang, C. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00005-0 · Cited by 91
Self-citationWang, C., Li, Z., Fu, M., Bouras, T., & Pestell, R. G. (2004) · Cancer treatment and research · doi:10.1007/1-4020-7847-1_11 · Cited by 88
Logan, I. R., Gaughan, L., McCracken, S. R., Sapountzi, V., Leung, H. Y., & Robson, C. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00147-06 · Cited by 88
Messner, E. A., Steele, T. M., Tsamouri, M. M., Hejazi, N., Gao, A. C., Mudryj, M. M., & Ghosh, P. (2020) · Biomedicines · doi:10.3390/biomedicines8100422 · Cited by 92
Hsu, C.-L., Chen, Y.-L., Yeh, S., Ting, H.-J., Hu, Y.-C., Lin, H., Wang, X., & Chang, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211908200 · Cited by 85
Self-citationPost-translational modifications of the progesterone receptors
Abdel-Hafiz, H. A., & Horwitz, K. B. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.12.008 · Cited by 93
Yang, Z., Chang, Y., Miyamoto, H., Ni, J., Niu, Y., Chen, Z.-D., Chen, Y., Yao, J. L., di Sant'Agnese, P. A., & Chang, C. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0104 · Cited by 83
Self-citationMolecular pathology of the androgen receptor in male (in)fertility
Gottlieb, B., Lombroso, R., Beitel, L. K., & Trifiro, M. A. (2005) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60802-4 · Cited by 82
Non-monotonic dose–response relationship in steroid hormone receptor-mediated gene expression
Li, L., Andersen, M. E., Heber, S., & Zhang, Q. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0003 · Cited by 83
AR Variant ARv567es Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer
Liu, G., Sprenger, C. C. T., Sun, S., Epilepsia, K. S., Haugk, K. L., Zhang, X., Coleman, I. M., Nelson, P. S., & Plymate, S. R. (2013) · Neoplasia · doi:10.1593/neo.13784 · Cited by 83
Molecular basis for the antiandrogen withdrawal syndrome
Miyamoto, H., Rahman, M. M., & Chang, C. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10757 · Cited by 81
Self-citationAndrogen receptor corepressors and prostate cancer
Burd, C. J., Morey, L. M., & Knudsen, K. E. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01115 · Cited by 83
The roles of sex steroid receptor coregulators in cancer.
Gao, X., Loggie, B. W., & Nawaz, Z. (2002) · Molecular Cancer · doi:10.1186/1476-4598-1-7 · Cited by 80
Link, K. A., Balasubramaniam, S., Sharma, A. M., Comstock, C. E. S., Godoy‐Tundidor, S., Powers, N., Cao, K. H., Haelens, A., Claessens, F., Revelo, M. P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6392 · Cited by 79
A type I DnaJ homolog, DjA1, regulates androgen receptor signaling and spermatogenesis
Terada, K., Yomogida, K., Imai, T., Kiyonari, H., Takeda, N., Kadomatsu, T., Yano, M., Aizawa, S., & Mori, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600549 · Cited by 79
Zhu, D., Hadoke, P. W. F., Wu, J., Vesey, A. T., Lerman, D. A., Dweck, M. R., Newby, D. E., Smith, L. B., & MacRae, V. E. (2016) · Scientific Reports · doi:10.1038/srep24807 · Cited by 83
Implications of a polyglutamine tract in the function of the human androgen receptor
Callewaert, L., Christiaens, V., Haelens, A., Verrijdt, G., Verhoeven, G., & Claessens, F. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00902-1 · Cited by 80
Wang, H., Song, K. W., Sponseller, T. L., & Danielpour, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411575200 · Cited by 77
Oliver, S. S., & Denu, J. M. (2010) · ChemBioChem · doi:10.1002/cbic.201000474 · Cited by 78
A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR
Wolf, S. S., Patchev, V. K., & Obendorf, M. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.017 · Cited by 76
Zhou, X. (2010) · Journal of Andrology · doi:10.2164/jandrol.109.009266 · Cited by 76
Lyons, L. S., & Burnstein, K. L. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0346 · Cited by 74
Vijayvargia, R., May, M. S., & Fondell, J. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3039 · Cited by 82
Dong, Y., Zhang, H., Gao, A. C., Marshall, J. R., & Ip, C. C. Y. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0124 · Cited by 76
Effect of pubertal nano-TiO2 exposure on testosterone synthesis and spermatogenesis in mice
Jia, F., Sun, Z., Yan, X., Zhou, B., & Wang, J. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1167-5 · Cited by 78
Gentile, M. A., Nantermet, P. V., Vogel, R. L., Phillips, R., Holder, D., Hodor, P. G., Cheng, C., Dai, H. A., Freedman, L. P., & Ray, W. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0048 · Cited by 75
The LATS2/KPM Tumor Suppressor Is a Negative Regulator of the Androgen Receptor
Powzaniuk, M., McElwee-Witmer, S., Vogel, R. L., Hayami, T., Rutledge, S. J., Chen, F., Harada, S.-I., Schmidt, A., Rodan, G. A., Freedman, L. P., et al. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0065 · Cited by 73
Uncovering sex-specific mechanisms of action of testosterone and redox balance
Cruz‐Topete, D., Dominic, P. S., & Stokes, K. Y. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101490 · Cited by 77
Effects and mechanisms of pyrethroids on male reproductive system
Wang, Q., Shen, J., Zhang, R., Hong, J., Li, Z., Ding, Z., Wang, H.-X., Zhang, J., Zhang, M., & Xu, L. (2020) · Toxicology · doi:10.1016/j.tox.2020.152460 · Cited by 70
Callewaert, L., Verrijdt, G., Haelens, A., & Claessens, F. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0313 · Cited by 72
Gong, J.-Y., Zhu, J., Goodman, O. B., Pestell, R. G., Schlegel, P. N., Nanus, D. M., & Shen, R. (2006) · Oncogene · doi:10.1038/sj.onc.1209231 · Cited by 72
Androgen receptor‐related diseases: what do we know?
Shukla, G. C., Plaga, A. R., Shankar, E., & Gupta, S. (2016) · Andrology · doi:10.1111/andr.12167 · Cited by 77
Fu, J., Jiang, J., Li, J., Wang, S., Shi, G. W., Feng, Q. F., White, E., Qin, J., & Wong, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808988200 · Cited by 69
Synergistic Effects of Coactivators GRIP1 and β-Catenin on Gene Activation
Li, H., Kim, J. H., Koh, S. S., & Stallcup, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311374200 · Cited by 70
Sex steroids receptors, hypertension, and vascular ageing
Connelly, P. J., Casey, H., Montezano, A. C. I., Touyz, R. M., & Delles, C. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00576-7 · Cited by 70
Chen, S.-T., Okada, M., Nakato, R., Izumi, K., Bando, M., & Shirahige, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628255 · Cited by 69
Léotoing, L., Meunier, L., Manin, M., Mauduit, C., Decaussin‐Petrucci, M., Verrijdt, G., Claessens, F., Benahmed, M., VEYSSIERE, G., Morel, L., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210942 · Cited by 69
Androgen Modulation of Coregulator Expression in Prostate Cancer Cells
Heemers, H. V., Regan, K. M., Schmidt, L. J., Anderson, S. K., Ballman, K. V., & Tindall, D. J. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0363 · Cited by 69
Du, X.-J., Fang, L., & Kiriazis, H. (2006) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2005.10.016 · Cited by 75
Son, B., Akishita, M., Iijima, K., Ogawa, S., Maemura, K., Yu, J., Takeyama, K., Kato, S., Eto, M., & Ouchi, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.055087 · Cited by 67
Recent developments in antiandrogens and selective androgen receptor modulators
Haendler, B., & Cleve, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.002 · Cited by 68
Hsu, C.-L., Chen, Y., Ting, H., Lin, W., Yang, Z., Zhang, Y., Wang, L., Wu, C., Chang, H., Yeh, S., et al. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0190 · Cited by 68
Self-citationLow-dose metformin exposure causes changes in expression of endocrine disruption-associated genes.
Niemuth, N., & Klaper, R. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.12.003 · Cited by 59
Wen, S., Niu, Y., & Huang, H. (2019) · Asian journal of urology · doi:10.1016/j.ajur.2019.11.001 · Cited by 67
Sex Steroid Receptors in Immune Cells
Kovats, S., Carreras, E., & Agrawal, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-02155-8_3 · Cited by 67
Jeong, B., Hong, C. Y., Chattopadhyay, S., Park, J., Gong, E., Kim, H., Chun, S., & Lee, K. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0065 · Cited by 67
Mechanisms of Disease: pharmacogenetics of testosterone therapy in hypogonadal men
Zitzmann, M. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0706 · Cited by 67
Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer
Obinata, D., Takayama, K., Urano, T., Murata, T., Kumagai, J., Fujimura, T., Ikeda, K., Horie‐Inoue, K., Homma, Y., Ouchi, Y., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26043 · Cited by 66
Metadata
- Authors
- Heinlein, C. A., & Chang, C.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- Chang, Chawnshang
- ORCID
- Chang, Chawnshang
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2002-04-01
- Volume
- 23
- Issue
- 2
- Pages
- 175-200
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2161123101
- Cited by
- 943
- References
- 357
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 28 · 2023: 22 · 2022: 30 · 2021: 19 · 2020: 26 · 2019: 25 · 2018: 23 · 2017: 30 · 2016: 32 · 2015: 48 · 2014: 34 · 2013: 48 · 2012: 44
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Rochester
- National Institutes of Health (14642)
- Medical Center, University of Rochester
- National Cancer Institute (CA55639, CA-715670)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen receptor, coregulators, transcriptional regulation, androgen signaling, histone modifications, chromatin remodeling, basal transcription machinery, ligand selectivity, DNA binding, prostate cancer, steroid hormone receptors, male sexual differentiation, spermatogenesis
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Male, Mutation, Prostatic Neoplasms, Receptors, Androgen, Transcription Factors, Transcription, Genetic, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review